This article is a correction to:
Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients
Renshi Li
Fengjie Zheng†
Xianghua Zhuang
Shihong Chen- Department of Endocrinology and Metabolism, Multidisciplinary Innovation Center for Nephrology of the Second Hospital of Shandong University, The Second Hospital of Shandong University, Ji’nan, Shandong, China
A Corrigendum on
Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients
by Li R, Zheng F, Xu P, Lv L, Mu Y, Zhuang X and Chen S (2024). Front. Endocrinol. 14:1299206. doi: 10.3389/fendo.2023.1299206
In the published article, there was an error in the author affiliations. The first author’s affiliation should be “Department of Endocrinology and Metabolism, Multidisciplinary Innovation Center for Nephrology of The Second Hospital of Shandong University, The Second Hospital of Shandong University, Ji’nan, Shandong Province, China”, instead of “Emergency department, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: type 2 diabetes mellitus, the thickness of retinal nerve fiber layer, interleukin-18, irisin, carboxymethyl lysine, receptors for AGEs, mild cognitive impairment
Citation: Li R, Zheng F, Xu P, Lv L, Mu Y, Zhuang X and Chen S (2024) Corrigendum: Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients. Front. Endocrinol. 15:1380375. doi: 10.3389/fendo.2024.1380375
Received: 01 February 2024; Accepted: 17 April 2024;
Published: 25 April 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Li, Zheng, Xu, Lv, Mu, Zhuang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xianghua Zhuang, Sd73095760653@163.com; Shihong Chen, chenshihong26@163.com
†These authors have contributed equally to this work